It is now widely accepted that inflammation is critical in cardiovascular diseases (CVD).
Here, studies are being conducted on how cyclic GMP-AMP synthase (cGAS), a component …

Cardiovascular diseases (CVDs) encompass a range of disorders, from congenital heart
malformation, cardiac valve, peripheral artery, coronary artery, cardiac muscle diseases, and …

Patients with preexisting cardiovascular disease or those at high risk for develo** the
condition are often offered exercise as a form of therapy. Patients with cancer who are at an …

Implementing Single-cell RNA sequencing (scRNA-seq) has significantly enhanced our
comprehension of cardiovascular diseases (CVDs), providing new opportunities to …

Cardiovascular disease is the leading cause of death, medical complications, and
healthcare costs. Although recent advances have been in treating cardiovascular disorders …

The health benefits of bioactive compounds are dependent on the amount of intake as well
as on the amount of these compounds that become bioavailable and bioaccessible. Various …

The achievement of genome-wide association studies (GWAS) has rapidly progressed our
understanding of the etiology of coronary artery disease (CAD). It unlocks new strategies to …

Interest in functional foods is continuously increasing, having the potential to be an ally in
reducing cardiometabolic risk factors. This study focuses on develo** and evaluating oat …

Complex coacervation can be used for controlled delivery of bioactive compounds (ie,
flaxseed oil and quercetin). This study investigated the co-encapsulation of flaxseed oil and …

Cardiovascular diseases (CVDs) are still leading to a significant number of deaths
worldwide despite the remarkable advancements in medical technology and pharmacology …